Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference

NEW BRUNSWICK, N.J., Nov. 28, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Piper Jaffray 23rd Annual Health Care Conference on Tuesday, Nov. 29th at The New York Palace, New York, NY.  Gary Pruden, Company Group Chairman, Ethicon will present in a session scheduled at 8:00 a.m. (Eastern Time).

The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

  

 

 

SOURCE Johnson & Johnson

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.